Clinical Trials Directory

Trials / Unknown

UnknownNCT02807935

The in Vivo Effect of Medical and Surgical Glaucoma Treatments on the Schlemm's Canal Micro-structure

The in Vivo Effect of Medical and Surgical Glaucoma Treatments on the Schlemm's Canal

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
440 (estimated)
Sponsor
Sheba Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of our current series of studies is to evaluate different glaucoma treatments in vivo effect on the conventional outflow pathway, and specifically on the Schlemm's canal (SC) anatomy using Enhanced Depth Imaging (EDI)-optical coherence tomography (OCT) . The images will be taken as part of the patients routine medical follow up (before starting the treatment, and 1,4 and 12 weeks afterwards) diameter, cross-sectional area and volume will be measured using commercially available 3-dimensional reconstruction. The series of studies will be divided into 3 branches, each branch contains different treatments.For each treatment different patients will be recruited. The branches are as following- 1. The surgical branch- 1. Before and after trabeculotomy 2. Before and after cataract surgery 3. Before and after vitrectomy surgery 4. Before and after XEN™ Gel Stent implant 2. The pharmacological branch- 1. Before and during the treatment with prostaglandins analogs 2. Before and during the treatment with alpha blockers 3. Before and during the treatment with beta blockers 4. Before and during the treatment with carbonic anhydrase inhibitor 3. The laser branch- 1. Before and after trabeculoplasty 2. Before and after laser iridotomy 3. Before and after yag capsulotomy laser

Conditions

Interventions

TypeNameDescription
DEVICEOptical coherence tomography imaging

Timeline

Start date
2016-07-01
Primary completion
2018-05-01
Completion
2018-05-01
First posted
2016-06-21
Last updated
2016-06-23

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02807935. Inclusion in this directory is not an endorsement.